⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL182923 | 1.00 | — | — | |
| SCHEMBL12292174 | 1.00 | — | — | |
| SCHEMBL183138 | 1.00 | — | — | |
| SCHEMBL183142 | 1.00 | — | — | |
| SCHEMBL4324438 | 1.00 | — | — | |
| SCHEMBL30613700 | 1.00 | — | — | |
| SCHEMBL18534632 | 1.00 | — | — | |
| SCHEMBL16566052 | 1.00 | — | — | |
| SCHEMBL182922 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL1775572 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117660389-A | Transaminase mutant and application thereof in preparation of chiral amine compounds | 浙江容锐科技有限公司 | 2024-03-08 | — | — | CN | claimed |
| US-20240317775-A1 | H4 Antagonist Compounds | NXERA PHARMA UK LIMITED (GB) | 2024-09-26 | — | — | US | disclosed |
| US-20240270740-A1 | INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF | VENTUS THERAPEUTICS U.S., INC. | 2024-08-15 | — | — | US | disclosed |
| CN-117660389-A | Transaminase mutant and application thereof in preparation of chiral amine compounds | 浙江容锐科技有限公司 | 2024-03-08 | — | — | CN | disclosed |
| US-20230312481-A1 | SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF | ARBUTUS BIOPHARMA CORP (CA) | 2023-10-05 | — | — | US | disclosed |
| US-9688668-B2 | Long chain base sphingosine kinase inhibitors | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2017-06-27 | — | — | US | disclosed |
| US-9688668-B2 | Long chain base sphingosine kinase inhibitors | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2017-06-27 | — | — | US | disclosed |
| US-9630958-B2 | Triazine compounds | SPHAERA PHARMA PTE. LTD. (SG) | 2017-04-25 | — | — | US | disclosed |
| US-9630958-B2 | Triazine compounds | SPHAERA PHARMA PTE. LTD. (SG) | 2017-04-25 | — | — | US | disclosed |
| US-20150210675-A1 | LONG CHAIN BASE SPHINGOSINE KINASE INHIBITORS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2015-07-30 | — | — | US | disclosed |
| US-20080274525-A1 | METHOD FOR THE PRODUCTION OF 2-BUTANOL | GEVO, INC. | 2008-11-06 | — | — | US | disclosed |
| US-20080176891-A1 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2008-07-24 | — | — | US | disclosed |
| US-20080146606-A1 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2008-06-19 | — | — | US | disclosed |
| WO-2008034860-A1 | PYRROLO[2, 3-B]PYRIDIN-4-YL-BENZENESULFONAMIDE COMPOUNDS AS IKK2 INHIBITORS | GLAXO GROUP LIMITED (GB) | 2008-03-27 | — | — | WO | disclosed |
| US-20070292927-A1 | producing 2-butanol and 2-butanone by the fermentive growth of a recombinant bacteria expressing a 2-butanol biosynthetic pathway | GEVO, INC. | 2007-12-20 | — | — | US | disclosed |
| WO-2007130521-A2 | FERMENTIVE PRODUCTION OF FOUR CARBON ALCOHOLS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-11-15 | — | — | WO | disclosed |
| US-20070259410-A1 | FERMENTIVE PRODUCTION OF FOUR CARBON ALCOHOLS | GEVO, INC. | 2007-11-08 | — | — | US | disclosed |
| WO-2007110649-A2 | PROCESS FOR THE PREPARATION OF 2,6,9-TRISUBSTITUTED PURINES | CYCLACEL LIMITED (GB) | 2007-10-04 | — | — | WO | disclosed |
| WO-2000012522-A1 | MACROLIDE LHRH ANTAGONISTS | ABBOTT LABORATORIES (US) | 2000-03-09 | — | — | WO | disclosed |
| US-6020521-A | Macrolide LHRH antagonists | ABBOTT LABORATORIES (US) | 2000-02-01 | — | — | US | disclosed |